Compliance with tricyclic antidepressants: the value of four different methods of assessment

被引:143
作者
George, CF
Peveler, RC
Heiliger, S
Thompson, C
机构
[1] Univ Southampton, Clin Pharmacol Grp, Southampton SO16 7PX, Hants, England
[2] Univ Southampton, Sch Med, Mental Hlth Grp, Southampton SO16 7PX, Hants, England
关键词
antidepressants; compliance;
D O I
10.1046/j.1365-2125.2000.00244.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To assess the advantages and disadvantages of four methods for studying compliance with antidepressants: self-report scores, tablet counts, a microprocessor (MEMS) container system and the assay of nordothiepin and dothiepin concentrations in plasma. Methods The techniques were used in 88 patients commencing tricyclic antidepressants in the setting of UK general practice. Results The MEMS system proved to be the most informative technique allowing identification of the precise time of container opening, the demonstration of drug holidays' and early cessation of therapy. Self-report scores (Morisky) proved a useful screening technique with a sensitivity of 72.2% and specificity of 74.1% for greater than or equal to 80% compliance. Although tablet counts were possible in 84 patients (95.5%) they were unreliable in 19 (21.6%). Blood concentration assays proved the least acceptable method to patients and were possible ill only 53 (60.2%). A ratio of nordothiepin:dothiepin greater than or equal to 1.1 claimed, by others, to identify noncompliance was only reliable when concentrations were low. Conclusions Both the MEMS system and self-report scores proved useful methods for identifying noncompliant patients in the setting of UK general practice. Although compliance was higher than reported in previous studies with 70 patients (79.5%) completing 6 weeks treatment, general practitioners tended to prescribe subtherapeutic doses.
引用
收藏
页码:166 / 171
页数:6
相关论文
共 15 条
  • [1] PLASMA-CONCENTRATIONS, INFORMATION AND THERAPY ADHERENCE DURING LONG-TERM TREATMENT WITH ANTIDEPRESSANTS
    ALTAMURA, AC
    MAURI, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (06) : 714 - 716
  • [2] BRODIE RR, 1977, J INT MED RES, V5, P387
  • [3] CONTINUATION THERAPY WITH AMITRIPTYLINE IN DEPRESSION
    COPPEN, A
    GHOSE, K
    MONTGOMERY, S
    RAO, VAR
    BAILEY, J
    JORGENSEN, A
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1978, 133 (JUL) : 28 - 33
  • [4] Donoghue J. M., 1996, British Journal of Psychiatry, V168, P164, DOI 10.1192/bjp.168.2.164
  • [5] ENGSTROM FW, 1991, PATIENT COMPLIANCE M, P187
  • [6] PLASMA-CONCENTRATIONS OF DOTHIEPIN AND ITS METABOLITES ARE NOT CORRELATED WITH CLINICAL EFFICACY IN MAJOR DEPRESSIVE-ILLNESS
    ILETT, KF
    BLYTHE, TH
    HACKETT, LP
    ONG, RTT
    TANNENBAUM, DA
    CLARKE, TMF
    [J]. THERAPEUTIC DRUG MONITORING, 1993, 15 (05) : 351 - 357
  • [7] DYNAMICS OF DRUG REGIMEN COMPLIANCE - ITS ASSESSMENT BY MICROPROCESSOR-BASED MONITORING
    KRUSE, W
    WEBER, E
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (06) : 561 - 565
  • [8] MacDonald TM, 1996, BRIT MED J, V313, P860
  • [9] MCGAVOCK HA, 1996, REV LIT DRUG ADHEREN
  • [10] CONCURRENT AND PREDICTIVE-VALIDITY OF A SELF-REPORTED MEASURE OF MEDICATION ADHERENCE
    MORISKY, DE
    GREEN, LW
    LEVINE, DM
    [J]. MEDICAL CARE, 1986, 24 (01) : 67 - 74